Surprised there is no subject on BCR.
The following is copied from Yahoo! Profile
C. R. Bard, Inc. develops, manufactures and markets health care products. Bard is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Bard's largest product group, urological diagnosis and intervention, includes Foley catheters, procedure kits and trays and related urine monitoring and collection systems, ureteral stents and specialty devices for incontinence, endoscopic procedures and stone removal. Vascular diagnosis and intervention products include peripheral angioplasty stents, catheters, guidewires, introducers and accessories and vena cava filters, electrophysiology products including cardiac mapping and electrophysiology laboratory systems, and diagnostic and temporary pacing electrode catheters, fabrics and meshes and implantable blood vessel replacements. Other products include biopsy products, specialty access catheters and ports, gastroenterological products and meshes for hernia repair.
As of 02/16/2000, share price is near the 52 weeks low. Trailing p/e is less than 19, p/b is under 4 and p/s is under 3. Projected peg is under 1. Debt is .44. She is trading at about 4x cash flow [EBITDA/Market Cap.] She is a S&P 5 stars and one of the Power Picks. S&P thinks it can grow by 15% in the next 3 years or so. It also thinks she is a potential takeover target. |
